Some studies have reported that the overall absence of KLK8 can significantly alleviate endothelial-mesenchymal transition and cardiac fibrosis in individuals with diabetes, while transgenic overexpression of KLK8 can lead to myocardial mesenchymal/perivascular fibrosis and endothelial-mesenchymal transition [13]. This evidence concerns the gene KLK8 and diabetes mellitus.